Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06498960 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Study acronym: STRIDE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Primary completion pushed from Dec 2026 to Jan 2027
    • Study completion pushed from Jun 2031 to Jul 2031
    • Study sites: 31 to 32
    v20
  2. Site details revised at 7 of 31 sitesv19
  3. Site details revised at 7 of 31 sitesv18
  4. Study sites: 30 to 31v17
  5. Study sites: 29 to 30v16
Show 14 earlier versionsHide 14 earlier versions
  1. Study sites: 28 to 29
    • Primary completion date: Jul 1, 2026 to Dec 2026
    • Study completion date: Jan 1, 2031 to Jun 2031
    v15
  2. Site contacts updated at 2 of 28 sitesv14
  3. Study sites: 27 to 28v13
  4. Study sites: 26 to 27v12
  5. Study sites: 25 to 26v11
  6. Study sites: 22 to 25v10
  7. Study sites: 15 to 22v9
  8. Study sites: 14 to 15v8
  9. Study sites: 11 to 14v7
  10. Study sites: 7 to 11v6
  11. Study sites: 1 to 7v5
  12. Start date changed from estimate of Nov 30, 2024 to Nov 26, 2024v4
  13. Lead sponsor: [Redacted] to CereVasc Incv3 Show 5 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: Jul 1, 2026
    • Study completion date: Jan 1, 2031
    • Start date: Nov 30, 2024
    • Study title expanded, about 2 words
  14. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, multi-center, randomized, controlled trial of the eShunt System in the treatment of patients with normal pressure hydrocephalus.
Trial Details
NCT Number NCT06498960
Lead Sponsor CereVasc Inc
Conditions
(from sponsor)		 Normal Pressure Hydrocephalus
Related terms Hydrocephalus, Normal Pressure
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov